New research reveals that patients who discontinue popular slimming jabs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who halt conventional lifestyle regimens.
Research printed in a prominent medical journal demonstrates that while obese people frequently drop a large proportion of their total mass while on the medication, the weight returns at an average rate of nearly a kilo each month after stopping.
"Individuals using these drugs need to be cognizant of the potential of quick rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.
This pace of recovery suggests a return to original weight in about one and a half years.
Analyzing Approaches
The study, which reviewed 37 of studies involving thousands of patients, contrasted the results of these new drugs with conventional dieting.
Scientists note that people who lose weight through lifestyle changes alone generally have a less rapid creep back—perhaps 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Experts suggest the mode of action of the jabs accounts for the accelerated weight return.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Artificially providing the hormone levels far above than the body's typical production could lead to the body to produce less of its own natural hormone, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication results in appetite is uncontrolled, making binge eating a significant risk."
An Ongoing Issue?
Health authorities recommend the jabs for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
Professionals contend that, considering the significant potential of weight regain, the therapy might need to be ongoing.
This view is reinforced by pharmaceutical companies, who state that the findings "highlight the chronic character of obesity," similar to managing diseases like high blood pressure.
Patient Experiences
Individuals who have come off the jabs report a intense return of appetite.
"It was like a switch flipping and I was suddenly extremely hungry," said an individual.
The struggle is exacerbated if individuals have not developed lasting lifestyle or habit modifications during therapy.
Widespread Interest
Recent estimates indicate that millions of people in the UK have tried these injections in the past year, with demand continuing to grow.
- Use is more common among women than males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers caution that while these medications are effective tools for weight loss, they are not a permanent cure and maintained weight loss hinges on integrated lifestyle changes.
